NLRP1 inflammasome is activated in patients with medial temporal lobe epilepsy and contributes to neuronal pyroptosis in amygdala kindling-induced rat model
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NLRP1 inflammasome is activated in patients with medial temporal lobe epilepsy and contributes to neuronal pyroptosis in amygdala kindling-induced rat model
Authors
Keywords
NLRP1, pyroptosis, inflammasome, Caspase-1, temporal lobe epilepsy
Journal
Journal of Neuroinflammation
Volume 12, Issue 1, Pages 18
Publisher
Springer Nature
Online
2015-01-27
DOI
10.1186/s12974-014-0233-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inflammasomes in the CNS
- (2014) John G. Walsh et al. NATURE REVIEWS NEUROSCIENCE
- Amyloid-β induces NLRP1-dependent neuronal pyroptosis in models of Alzheimer’s disease
- (2014) M-S Tan et al. Cell Death & Disease
- Histopathological evidence that hippocampal atrophy following status epilepticus is a result of neuronal necrosis
- (2013) Gogi Kumar et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- The NLRP3 Inflammasome in Alzheimer’s Disease
- (2013) Meng-Shan Tan et al. MOLECULAR NEUROBIOLOGY
- Pharmacological blockade of IL-1β/IL-1 receptor type 1 axis during epileptogenesis provides neuroprotection in two rat models of temporal lobe epilepsy
- (2013) F.M. Noe et al. NEUROBIOLOGY OF DISEASE
- Cell death and survival mechanisms are concomitantly active in the hippocampus of patients with mesial temporal sclerosis
- (2013) N. Dericioglu et al. NEUROSCIENCE
- Genome-Wide microRNA Profiling of Rat Hippocampus after Status Epilepticus Induced by Amygdala Stimulation Identifies Modulators of Neuronal Apoptosis
- (2013) Zhen Sun et al. PLoS One
- NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1 processing via the NLRP1 inflammasome
- (2013) C. B. Levandowski et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke
- (2013) D Yang-Wei Fann et al. Cell Death & Disease
- Astrocyte dysfunction in temporal lobe epilepsy: K+ channels and gap junction coupling
- (2012) Christian Steinhäuser et al. GLIA
- NLRP1 Inflammasome Activation Induces Pyroptosis of Hematopoietic Progenitor Cells
- (2012) Seth L. Masters et al. IMMUNITY
- NLRP1-Dependent Pyroptosis Leads to Acute Lung Injury and Morbidity in Mice
- (2012) M. Kovarova et al. JOURNAL OF IMMUNOLOGY
- Caspase-1: is IL-1 just the tip of the ICEberg?
- (2012) A Denes et al. Cell Death & Disease
- Interleukin-1 type 1 receptor/Toll-like receptor signalling in epilepsy: the importance of IL-1beta and high-mobility group box 1
- (2011) M. Maroso et al. JOURNAL OF INTERNAL MEDICINE
- The Role of Potassium in Inflammasome Activation by Bacteria
- (2010) Cecilia S. Lindestam Arlehamn et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The role of inflammation in epilepsy
- (2010) Annamaria Vezzani et al. Nature Reviews Neurology
- Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies
- (2009) Patrick Kwan et al. EPILEPSIA
- Therapeutic Neutralization of the NLRP1 Inflammasome Reduces the Innate Immune Response and Improves Histopathology after Traumatic Brain Injury
- (2009) Juan Pablo de Rivero Vaccari et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors
- (2009) François Ghiringhelli et al. NATURE MEDICINE
- Pyroptosis: host cell death and inflammation
- (2009) Tessa Bergsbaken et al. NATURE REVIEWS MICROBIOLOGY
- Inhibition of the Inflammasome Complex Reduces the Inflammatory Response after Thromboembolic Stroke in Mice
- (2008) Denise P Abulafia et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started